{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T14:52:06Z","timestamp":1795099926215,"version":"4.10.3"},"reference-count":71,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:p>Primary dysmenorrhea is defined as pain during the menstrual cycle in the absence of an identifiable cause. It is one of the most common causes of pelvic pain in women. Dysmenorrhea can negatively affect a woman's quality of life and interfere with daily activities. The pathophysiology of primary dysmenorrhea is likely a result of the cyclooxygenase pathway producing increased prostanoids, particularly prostaglandins (PGs). The increased PGs cause uterine contractions that restrict blood flow and lead to the production of anaerobic metabolites that stimulate pain receptors. Women with a history typical for primary dysmenorrhea can initiate empiric treatment without additional testing. Shared decision making is key to effective management of dysmenorrhea to maximize patient compliance and satisfaction. After a discussion of their risks and benefits, extremely effective empiric therapies are nonsteroidal antiinflammatory drugs and contraceptive hormonal therapy. Other treatments for primary dysmenorrhea can be employed solely or in combination with other modalities, but the literature supporting their use is not as convincing. The physician should initiate an evaluation for secondary dysmenorrhea if the patient does not report improved symptomatology after being compliant with their medical regimen.<\/jats:p>","DOI":"10.1097\/aog.0000000000004096","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T18:00:23Z","timestamp":1602180023000},"page":"1047-1058","source":"Crossref","is-referenced-by-count":330,"title":["Primary Dysmenorrhea"],"prefix":"10.1097","volume":"136","author":[{"given":"Elizabeth","family":"Ferries-Rowe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna S.","family":"Archer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,10,6]]},"reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pop.2008.10.004","article-title":"Dysmenorrhea","volume":"36","author":"Morrow","year":"2009","journal-title":"Prim Care"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/epirev\/mxt009","article-title":"The prevalence and risk factors of dysmenorrhea","volume":"36","author":"Ju","year":"2014","journal-title":"Epidemiol Rev"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/01.AOG.0000230214.26638.0c","article-title":"Primary dysmenorrhea: advances in pathogenesis and management","volume":"108","author":"Dawood","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"e026186","DOI":"10.1136\/bmjopen-2018-026186","article-title":"Productivity loss due to menstruation-related symptoms: a nationwide cross-sectional survey among 32 748 women","volume":"9","author":"Schoep","year":"2019","journal-title":"BMJ Open"},{"key":"R5-20230711","first-page":"154","article-title":"Dysmenorrhea","volume":"30","author":"Dawood","year":"2008","journal-title":"Glob Libr Womens Med"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/AOG.0000000000003060","article-title":"Unmet menstrual hygiene needs among low-income women","volume":"133","author":"Sebert Kuhlmann","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/humupd\/dmv039","article-title":"What we know about primary dysmenorrhea today: a critical review","volume":"21","author":"Iacovides","year":"2015","journal-title":"Hum Reprod Update"},{"key":"R8-20230711","first-page":"0183","article-title":"Dysmenorrhoea","volume":"2014","author":"Latthe","year":"2014","journal-title":"BMJ Clin Evid"},{"key":"R9-20230711","first-page":"341","article-title":"Diagnosis and initial management of dysmenorrhea","volume":"89","author":"Osayande","year":"2014","journal-title":"Am Fam Physician"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1471-0528.2004.00090.x","article-title":"The natural history of primary dysmenorrhoea: a longitudinal study","volume":"111","author":"Weissman","year":"2004","journal-title":"BJOG"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0079-6123(02)39030-7","article-title":"Involvement of oxytocin and vasopressin in the pathophysiology of preterm labor and primary dysmenorrhea","volume":"139","author":"Akerlund","year":"2002","journal-title":"Prog Brain Res"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000010319","article-title":"Effects of a vasopressin antagonist in women with dysmenorrhea","volume":"50","author":"Valentin","year":"2000","journal-title":"Gynecol Obstet Invest"},{"key":"R13-20230711","first-page":"251","article-title":"Primary dysmenorrhea and uterine blood flow: a color Doppler study","volume":"50","author":"Altunyurt","year":"2005","journal-title":"J Reprod Med"},{"key":"R14-20230711","first-page":"2333392814567920","article-title":"A review of select centralized pain syndromes: relationship with childhood sexual abuse, opiate prescribing, and treatment implications for the primary care physician","volume":"2","author":"Spiegel","year":"2015","journal-title":"Health Serv Res Manag Epidemiol"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/S0002-9378(97)70083-8","article-title":"The association of sexual abuse with pelvic pain complaints in a primary care population","volume":"177","author":"Jamieson","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/AOG.0b013e3181cb50b5","article-title":"Noncontraceptive uses of hormonal contraceptives. Practice Bulletin No. 110. American College of Obstetricians and Gynecologists","volume":"115","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/01.AOG.0000160430.61799.f6","article-title":"Extended use of transdermal norelgestromin\/ethinyl estradiol: a randomized trial","volume":"105","author":"Stewart","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/humrep\/del162","article-title":"Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 \u00b5g ethinyl estradiol and 3 mg drospirenone","volume":"21","author":"Milsom","year":"2006","journal-title":"Hum Reprod"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jogc.2016.12.023","article-title":"No. 345-primary dysmenorrhea consensus guideline","volume":"39","author":"Burnett","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1001\/archinte.164.18.1965","article-title":"Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review","volume":"164","author":"Gomes","year":"2004","journal-title":"Arch Intern Med"},{"key":"R21-20230711","first-page":"191","article-title":"Oral contraceptives and venous thromboembolism: a systematic review and meta-analysis","volume":"35","author":"Manzoli","year":"2012","journal-title":"Drug Saf"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/01.AOG.0000279448.62221.a8","article-title":"Risk of thromboembolism in women taking ethinylestradiol\/drospirenone and other oral contraceptives","volume":"110","author":"Seeger","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"h2135","DOI":"10.1136\/bmj.h2135","article-title":"Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases","volume":"350","author":"Vinogradova","year":"2015","journal-title":"BMJ"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.thromres.2010.08.010","article-title":"Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study","volume":"126","author":"Barsoum","year":"2010","journal-title":"Thromb Res"},{"key":"R26-20230711","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001\u20139","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"R27-20230711","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0010-7824(01)00234-7","article-title":"Risk of venous thromboembolism from oral contraceptives containing gestodene and desogestrel versus levonorgestrel: a meta-analysis and formal sensitivity analysis","volume":"64","author":"Hennessy","year":"2001","journal-title":"Contraception"},{"key":"R28-20230711","doi-asserted-by":"crossref","first-page":"E1319","DOI":"10.1503\/cmaj.110463","article-title":"Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study","volume":"183","author":"Gronich","year":"2011","journal-title":"CMAJ"},{"key":"R29-20230711","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ijgo.12455","article-title":"A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception","volume":"141","author":"Dragoman","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"issue":"suppl 2","key":"R30-20230711","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/14730782.2000.12288982","article-title":"Clinical profile of Implanon: a single-rod etonogestrel contraceptive implant","volume":"5","author":"Croxatto","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R31-20230711","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.contraception.2009.02.008","article-title":"Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons","volume":"80","author":"Hubacher","year":"2009","journal-title":"Contraception"},{"key":"R32-20230711","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ajog.2018.12.008","article-title":"Levonorgestrel intrauterine system associated amenorrhea: a systematic review and metaanalysis","volume":"220","author":"Sergison","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"R33-20230711","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jpag.2019.03.008","article-title":"Assessing weight status in adolescent and young adult users of the etonogestrel contraceptive implant","volume":"32","author":"Romano","year":"2019","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R34-20230711","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1097\/01.AOG.0000450758.95422.c8","article-title":"Depot medroxyprogesterone acetate and bone effects. Committee Opinion No. 602. American College of Obstetricians and Gynecologists","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R35-20230711","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1136\/bmj.332.7550.1134","article-title":"Diagnosis and management of dysmenorrhoea","volume":"332","author":"Proctor","year":"2006","journal-title":"BMJ"},{"key":"R36-20230711","doi-asserted-by":"crossref","first-page":"1744806918770320","DOI":"10.1177\/1744806918770320","article-title":"Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs for patients with primary dysmenorrhea: a network meta-analysis","volume":"14","author":"Feng","year":"2018","journal-title":"Mol Pain"},{"key":"R38-20230711","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1517\/14656566.2012.725045","article-title":"Dysmenorrhea in adolescents and young adults: an update on pharmacological treatments and management strategies","volume":"13","author":"Harel","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"R39-20230711","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1097\/AOG.0000000000002978","article-title":"Dysmenorrhea and endometriosis in the adolescent. ACOG Committee Opinion No. 760. American College of Obstetricians and Gynecologists","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R40-20230711","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jogc.2016.12.023","article-title":"No. 345-primary dysmenorrhea consensus guideline","volume":"39","author":"Burnett","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"key":"R41-20230711","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1701-2163(16)30403-0","article-title":"Nitroglycerin as a uterine relaxant: a systematic review","volume":"24","author":"Morgan","year":"2002","journal-title":"J Obstet Gynaecol Can"},{"key":"R42-20230711","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0020-7292(00)00185-5","article-title":"Transdermal glyceryl trinitrate in the management of primary dysmenorrhea","volume":"69","author":"Moya","year":"2000","journal-title":"Int J Gynaecol Obstet"},{"key":"R43-20230711","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/030006059702500106","article-title":"Transdermal nitroglycerine in the management of pain associated with primary dysmenorrhoea: a multinational pilot study","volume":"25","author":"R\u00e9","year":"1997","journal-title":"Int Med Res"},{"key":"R45-20230711","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1471-0528.1978.tb10469.x","article-title":"Effects of nifedipine on myometrial activity and lower abdominal pain in women with primary dysmenorrhoea","volume":"85","author":"Andersson","year":"1978","journal-title":"Br J Obstet Gynaecol"},{"key":"R46-20230711","doi-asserted-by":"crossref","first-page":"e3011","DOI":"10.1136\/bmj.e3011","article-title":"How effective are non-drug, non-surgical treatments for primary dysmenorrhoea?","volume":"344","author":"Khan","year":"2012","journal-title":"BMJ"},{"key":"R47-20230711","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1080\/09513590.2018.1450377","article-title":"Vitamin E and fish oil, separately or in combination, on treatment of primary dysmenorrhea: a double-blind, randomized clinical trial","volume":"34","author":"Sadeghi","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"R49-20230711","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0891-5849(01)00817-6","article-title":"Mechanism of vitamin E inhibition of cyclooxygenase activity in macrophages from old mice: role of peroxynitrite","volume":"32","author":"Beharka","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"R50-20230711","doi-asserted-by":"crossref","first-page":"462","DOI":"10.5468\/ogs.2019.62.6.462","article-title":"Comparison of the effect of vitamin E, vitamin D and ginger on the severity of primary dysmenorrhea: a single-blind clinical trial","volume":"62","author":"Pakniat","year":"2019","journal-title":"Obstet Gynecol Sci"},{"key":"R51-20230711","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijgo.2011.11.019","article-title":"Effect of omega-3 fatty acids on intensity of primary dysmenorrhea","volume":"117","author":"Rahbar","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"key":"R52-20230711","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ctim.2018.01.001","article-title":"Medicinal plants for primary dysmenorrhoea: a systematic review","volume":"37","author":"Pellow","year":"2018","journal-title":"Complement Ther Med"},{"key":"R54-20230711","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.150.3699.971","article-title":"Pain mechanisms: a new theory","volume":"150","author":"Melzack","year":"1965","journal-title":"Science"},{"key":"R55-20230711","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ctcp.2016.05.001","article-title":"TENS and heat therapy for pain relief and quality of life improvement in individuals with primary dysmenorrhea: a systematic review","volume":"24","author":"Igwea","year":"2016","journal-title":"Complement Ther Clin Pract"},{"key":"R57-20230711","first-page":"137","article-title":"The effects of acupressure on severity of primary dysmenorrhea","volume":"6","author":"Gharloghi","year":"2012","journal-title":"Patient Prefer Adherence"},{"key":"R58-20230711","doi-asserted-by":"crossref","first-page":"138537","DOI":"10.1155\/2013\/138537","article-title":"Auricular acupressure to improve menstrual pain and menstrual distress and heart rate variability for primary dysmenorrhea in youth with stress","volume":"2013","author":"Wang","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"R60-20230711","first-page":"46","article-title":"Acupuncture for primary dysmenorrhea: a meta-analysis of randomized controlled trials","volume":"23","author":"Liu","year":"2017","journal-title":"Altern Ther Health Med"},{"key":"R61-20230711","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1471-0528.2010.02489.x","article-title":"Acupuncture for primary dysmenorrhoea: a systematic review","volume":"117","author":"Cho","year":"2010","journal-title":"BJOG"},{"key":"R62-20230711","doi-asserted-by":"crossref","first-page":"e11007","DOI":"10.1097\/MD.0000000000011007","article-title":"The efficacy and safety of acupuncture in women with primary dysmenorrhea: a systematic review and meta-analysis","volume":"97","author":"Woo","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R63-20230711","doi-asserted-by":"crossref","first-page":"1791258","DOI":"10.1155\/2017\/1791258","article-title":"Electroacupuncture is beneficial for primary dysmenorrhea: the evidence from meta-analysis of randomized controlled trials","volume":"2017","author":"Yu","year":"2017","journal-title":"Evid Based Complement Alternat Med"},{"key":"R64-20230711","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/acupmed-2016-011110","article-title":"Treating primary dysmenorrhoea with acupuncture: a narrative review of the relationship between acupuncture \u201cdose\u201d and menstrual pain outcomes","volume":"34","author":"Armour","year":"2016","journal-title":"Acupunct Med"},{"key":"R65-20230711","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jcm.2015.12.002","article-title":"Effect of ThermaCare HeatWraps and Icy Hot cream\/patches on skin and quadriceps muscle temperature and blood flow","volume":"15","author":"Petrofsky","year":"2016","journal-title":"J Chiropr Med"},{"key":"R67-20230711","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/jmwh.12729","article-title":"Yoga and quality of life in women with primary dysmenorrhea: a systematic review","volume":"63","author":"McGovern","year":"2018","journal-title":"J Midwifery Womens Health"},{"key":"R68-20230711","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/07448481.1985.9935033","article-title":"Effects of aerobic training on primary dysmenorrhea symptomatology in college females","volume":"33","author":"Israel","year":"1985","journal-title":"J Am Coll Health"},{"key":"R69-20230711","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/jehp.jehp_79_17","article-title":"The effect of aerobic exercise on primary dysmenorrhea: a clinical trial study","volume":"7","author":"Dehnavi","year":"2018","journal-title":"J Educ Health Promot"},{"key":"R70-20230711","doi-asserted-by":"crossref","first-page":"255.e1","DOI":"10.1016\/j.ajog.2018.04.001","article-title":"Physical activity for primary dysmenorrhea: a systematic review and meta-analysis of randomized controlled trials","volume":"219","author":"Matthewman","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R71-20230711","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ypmed.2003.09.042","article-title":"The effect of office-based physician's adolescent exercise behavior","volume":"38","author":"Ortega-Sanchez","year":"2004","journal-title":"Prev Med"},{"key":"R72-20230711","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jmig.2016.08.825","article-title":"Effect of radiofrequency endometrial ablation on dysmenorrhea","volume":"23","author":"Wyatt","year":"2016","journal-title":"J Minim Invasive Gynecol"},{"key":"R73-20230711","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/AOG.0b013e31818c1766","article-title":"Probability of hysterectomy after endometrial ablation","volume":"112","author":"Longinotti","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R75-20230711","first-page":"279","article-title":"Uterine prolapse after laparoscopic uterosacral transection in nulliparous airborne trainees. A report of three cases","volume":"41","author":"Davis","year":"1996","journal-title":"J Reprod Med"},{"key":"R76-20230711","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ejogrb.2013.12.017","article-title":"Psychological outcomes after hysterectomy for benign conditions: a systematic review and meta-analysis","volume":"174","author":"Darwish","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R77-20230711","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jogc.2019.08.006","article-title":"Evaluating the prevalence of regret with the decision to proceed with a hysterectomy in women younger than age 35","volume":"42","author":"Bougie","year":"2020","journal-title":"J Obstet Gynaecol Can"},{"key":"R79-20230711","first-page":"1","article-title":"US medical eligibility criteria for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"R80-20230711","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jmig.2015.06.012","article-title":"Combined endometrial ablation and levonorgestrel intrauterine system use in women with dysmenorrhea and heavy menstrual bleeding: novel approach for challenging cases","volume":"22","author":"Papadakis","year":"2015","journal-title":"J Minim Invasive Gynecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T06:15:49Z","timestamp":1696832149000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004096"}},"subtitle":["Diagnosis and Therapy"],"short-title":[],"issued":{"date-parts":[[2020,10,6]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004096","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,6]]}}}